What to do with foundation therapies for heart failure for patients with end-stage kidney disease on haemodialysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sherna F,Adenwalla

第一单位： Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.;Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.

作者： Sherna F,Adenwalla ^[1] ; Katherine L,Hull ^[1] ; Matthew Pm,Graham-Brown ^[1]

作者单位： Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.;Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK. ^[1]

关键词 Dialysis End-stage kidney disease Foundation therapies Heart failure Management

主题词人类(Humans);心力衰竭(Heart Failure);肾透析(Renal Dialysis);肾功能衰竭, 慢性(Kidney Failure, Chronic);肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);肾素-血管紧张素系统(Renin-Angiotensin System)

DOI 10.12968/hmed.2023.0452

PMID 38708982

发布时间 2024-05-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交